Pharmacogenomics News: Breaking Pharmacogenomics News, Comments and Articles. - Page: 2

LI-COR Analyzers Monitoring Carbon Dioxide Worldwide as Atmospheric Levels Reach 400 parts per million

On May 13, the National Oceanic and Atmospheric Administration (NOAA) reported a preliminary daily average carbon dioxide (CO2) reading of 400.07 parts per million (ppm) at the Mauna Loa Observatory on the Big Island of Hawaii. On May 9, a reading over 400 ppm was reported at the site for the first time ever. But that reading (400.03 ppm) was later revised...

BioDuro Opens State-of-the-Art Discovery Lab in Shanghai

New facility offers customized portfolio of services to meet expanding client demand BioDuro, A PPD® Company, today announced it has opened a new state-of-the-art laboratory in Shanghai, strengthening its ability to provide biopharmaceutical clients an extensive range of customized drug discovery services in Asia Pacific. The new lab also enabl...

Edgemont Capital Completes Sale Of Vince & Associates Clinical Research

NEW YORK, May 15, 2013 /PRNewswire/ -- Edgemont Capital Partners ("Edgemont"), a specialty investment bank focused on the merger and acquisition advisory needs of healthcare companies, has acted as exclusive financial advisor to Vince and Associates Clinical Research ("Vince and Associates") in its sale to Altasciences Group.  Vince and Associates manages complex early development clinical dr...

Illumina Announces Partnerships to Automate TruSeq® and Nextera® Sample Preparation Kits

Automation Methods Developed By Leading Vendors Will Enable Customers to Accelerate Testing and Discovery Illumina, Inc. (NASDAQ:ILMN) today announced it is collaborating with leading providers of liquid handling robotic platforms to develop automation methods for its best-in-class TruSeq and Nextera Sample Preparation kits. Initial partners in this ef...

Plandai Biotechnology, Inc. Announces Positive Anti-Malaria Test Results Using Phytofare™ Extract

SEATTLE, May 15, 2013 /PRNewswire/ -- Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical and pharmaceutical, today announced that the Company's Phytofare™ Catechin Extract has proven effective in killing the malaria parasite, plasmodium falciparum, in analytical tests developed by and condu...

Cliff Reid on Complete After BGI

MendelsPod | Complete Genomics CEO, Cliff Reid, talks about the future after BGI’s buyout.

Adaptrin® Announced Today That Its Scientifically Proven, All-Natural Herbal Supplement Has 21 Elements That Bolster Healthy Cardiovascular and Immune Functions

Adaptrin®, a scientifically proven, all-natural herbal supplement drawing from traditional Tibetan medicine announced today, after its re-release this month, that it uses its 21 different herbs and minerals to serve as a bioprotectant that alleviates stress on the body. Adaptrin’s bioprotectant ingredients prevent wear and tear damage to the body’s cells and tissues, and the resulting pr...

TGen joins Riddell to advance athlete concussion detection and treatment

Head protection plays a vital role in the health and safety of any athlete participating in helmeted sports. In a move that could help revolutionize football player safety, the Translational Genomics Research Institute, and Easton-Bell Sports through...

Cancer Genetics to Sponsor and Host Roundtable at BioNJ Diagnostics & Personalized Medicine Innovation Summit

Cancer Genetics, Inc. (OTCQB: CGIX) ("CGI" or the "Company"), a leader in oncology-focused personalized medicine, will sponsor and host a roundtable discussion at the second annual BioNJ Diagnostics & Personalized Medicine Innovation Summit on Thursday, June 6, 2013 at Sanofi’s U.S. headquarters in Bridgewater, NJ. The BioNJ Diagnostics &...

[Eisai]’s [H3 Biomedicine], [Horizon Discovery] identify cancer targets

[Eisai Co. Ltd.]’s US cancer genomics subsidiary [H3 Biomedicine Inc.] and five-year-old translational genomics and personalized medicine firm [Horizon Discovery Ltd.] will collaborate to identify and validate cancer genome drug targets.

TGen and Riddell Announce Partnership for Biomarker Study of Concussive Injuries

Riddell’s Sideline Response System to provide real-time head impact data on athletes, combined with TGen’s molecular clues from players with concussions to unlock keys to monitoring of head injury Head protection plays a vital role in the health and safety of any athlete participating in helmeted sports. In a move that could help revolutionize foot...

Computational Biology Market - New Market Research Report Published by Transparency Market Research

According to a new market report published by Transparency Market Research, "Computational Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics, Pharmacogenomics, Pharmacokinetics, Human Simulation Software, Drug Discovery & Development) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," in 2013, the global computational bi...

Vince and Associates Clinical Research Joins the Altasciences Group

The Altasciences Group is proud to announce the addition of Vince and Associates Clinical Research to its team providing comprehensive Phase I/IIa clinical drug development capabilities. Based in Overland Park, Kansas since 2001, Vince and Associates has become an established industry leader in the successful recruitment and retention of sp...

J. Craig Venter Institute's Mobile Genomics Lab Launches First School Visits in San Diego County

LA JOLLA, Calif., May 14, 2013 /PRNewswire-USNewswire/ -- The J. Craig Venter Institute (JCVI) announced today the launch of their mobile genomics laboratory program in the San Diego, California area.  The DiscoverGenomics! Mobile Laboratory is a self-sufficient laboratory on wheels providing middle school students and teachers an opportunity to learn current bioscience concepts and to m...

University of Maryland Medical Center Launches Genetic-Testing Program For Cardiac Stent Patients

BALTIMORE, May 14, 2013 /PRNewswire-USNewswire/ -- Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center now can receive long-term therapy based on information found in their genes. As part of a new personalized medicine initiative, the medical center is offering genetic testing to help doctors determine which medication a patient should take...

Post-polypectomy Bleeding in Patients on Clopidogrel

Are patients taking clopidogrel undergoing polypectomy at a greater risk for bleeding after the procedure and, if so, how could it be prevented? Alimentary Pharmacology & Therapeutics

e-Therapeutics preliminary results for the year ended 31 January 2013.

14 May 2013 – e-Therapeutics plc (“e-Therapeutics”; AIM: ETX), the drug discovery and development company, today announces its preliminary results for the year ended 31 January 2013. Highlights of 2012/13 (* = events after the 31 January 2013 year end; **announced today) Lead cancer drug ETS2101 enters clinic US phase I trial started in patients with brain cancer...

The Open Medicine Foundation Awarded Grant from the VMware Foundation to Accelerate Development of Patient-Centric Health Care Model

MT. VIEW, Calif., May 14, 2013 /PRNewswire-USNewswire/ -- The Open Medicine Institute (OMI), an organization with a mission to improve health care by applying a multi-disciplinary, "big data" approach, today announced that the Open Medicine Foundation (nonprofit 501(c)(3)), has been awarded a grant from the VMware Foundation.  The donation includes financial and consulting support from the vi...

Intra-Cellular Therapies Appoints Professor Sir Michael Rawlins to its Board of Directors

NEW YORK, May 14, 2013 /PRNewswire/ -- Intra-Cellular Therapies, Inc. ("ITI"), a biopharmaceutical company focused on the development of therapeutics for CNS disorders, is pleased to announce the appointment of Professor Sir Michael Rawlins, MD, FRCP, FMedSci, to its board of directors.  Sir Michael is an internationally respected figure in the field of drug safety, clinical effectivenes...

Study Shows Honokiol Supports Muscles During Intense Exercise*

SANTA ROSA, Calif., May 14, 2013 /PRNewswire/ -- Honokiol is a powerful polyphenol compound extracted from Magnolia officinalis bark. Extensive pre-clinical research shows that honokiol (pronounced ha-no-kee-ohl) supports cellular health and provides gentle relaxation, as well as being a potent antioxidant. In addition, a study published in the European Journal of Pharmacology has found t...

Entelos and Institute for Systems Biology Partner to Deliver Breakthrough Insights into Novel Drug Development

Collaboration connects gene expression data and physiological mechanistic model simulations that should illuminate best treatment for selected patients. San Mateo, CA (PRWEB) May 14, 2013 Entelos Holding Corp. (“Entelos” or “the Company”), a premier provider of physiological system modeling and services, and Seattle-based Institute for System Biology (ISB), the nonprofit pioneers of the s...

Data Sciences International (DSI) in Space

DSI Technology Used to Study Mice in Russian Space Mission St. Paul, MN (PRWEB) May 14, 2013 Data Sciences International (DSI) has taken part in an exciting study involving its products traveling to space. DSI was approached nearly four years ago by a European researcher working in collaboration with the European Space Agency and the Russian Space Agency on a study measuring the effects space tr...

e-Therapeutics’ Preliminary Results for the Year Ended 31 January 2013

e-Therapeutics plc (“e-Therapeutics”; AIM: ETX), the drug discovery and development company, today announces its preliminary results for the year ended 31 January 2013. Highlights of 2012/13 (* = events after the 31 January 2013 year end; **announced today) Lead cancer drug ETS2101 enters clin...

Deep-sea striving

This month's Genome Watch highlights a recent article that used single-cell genomics to characterize uncultivated archaea present in marine sediments.

bioskin® Presents 5th Dermatological Product Development Workshop June 13 - 14, 2013 in Munich, Germany

NAPA, Calif., May 13, 2013 /PRNewswire/ -- bioskin® is an organizer and sponsor for the 5th Dermatological Product Development Workshop for the AGAH (Association of Applied Human Pharmacology), to be held June 13 – 14, 2013, in Munich, Germany. Many of the key issues and challenges involved in the successful development of dermatological products will be addressed. Pra...